Clarkston Capital Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $698K | Hold |
6,500
| – | – | 0.01% | 115 |
|
2025
Q1 | $656K | Hold |
6,500
| – | – | 0.01% | 112 |
|
2024
Q4 | $581K | Hold |
6,500
| – | – | 0.01% | 116 |
|
2024
Q3 | $545K | Hold |
6,500
| – | – | 0.01% | 116 |
|
2024
Q2 | $501K | Hold |
6,500
| – | – | 0.01% | 120 |
|
2024
Q1 | $445K | Hold |
6,500
| – | – | 0.01% | 123 |
|
2023
Q4 | $376K | Hold |
6,500
| – | – | 0.01% | 124 |
|
2023
Q3 | $343K | Hold |
6,500
| – | – | 0.01% | 126 |
|
2023
Q2 | $352K | Hold |
6,500
| – | – | 0.01% | 128 |
|
2023
Q1 | $325K | Hold |
6,500
| – | – | 0.01% | 128 |
|
2022
Q4 | $301K | Hold |
6,500
| – | – | 0.01% | 142 |
|
2022
Q3 | $252K | Hold |
6,500
| – | – | 0.01% | 149 |
|
2022
Q2 | $242K | Sell |
6,500
-153
| -2% | -$5.7K | ﹤0.01% | 157 |
|
2022
Q1 | $295K | Buy |
6,653
+153
| +2% | +$6.78K | ﹤0.01% | 149 |
|
2021
Q4 | $276K | Hold |
6,500
| – | – | ﹤0.01% | 143 |
|
2021
Q3 | $282K | Hold |
6,500
| – | – | 0.01% | 127 |
|
2021
Q2 | $278K | Hold |
6,500
| – | – | 0.01% | 128 |
|
2021
Q1 | $251K | Buy |
+6,500
| New | +$251K | ﹤0.01% | 135 |
|